newsfilter
← Latest News
GlobeNewswire·

PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration ("FDA")

PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets